KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Capital Expenditures: 2020-2025

Historic Capital Expenditures for Ginkgo Bioworks Holdings (DNA) over the last 4 years, with Jun 2025 value amounting to $38,000.

  • Ginkgo Bioworks Holdings' Capital Expenditures fell 99.86% to $38,000 in Q2 2025 from the same period last year, while for Jun 2025 it was $36.5 million, marking a year-over-year decrease of 12.29%. This contributed to the annual value of $62.5 million for FY2024, which is 53.28% up from last year.
  • As of Q2 2025, Ginkgo Bioworks Holdings' Capital Expenditures stood at $38,000, which was down 99.50% from $7.6 million recorded in Q1 2025.
  • Ginkgo Bioworks Holdings' Capital Expenditures' 5-year high stood at $27.0 million during Q2 2024, with a 5-year trough of $38,000 in Q2 2025.
  • Its 3-year average for Capital Expenditures is $11.1 million, with a median of $10.6 million in 2023.
  • Its Capital Expenditures has fluctuated over the past 5 years, first skyrocketed by 443.04% in 2023, then crashed by 99.86% in 2025.
  • Over the past 5 years, Ginkgo Bioworks Holdings' Capital Expenditures (Quarterly) stood at $5.1 million in 2021, then soared by 401.47% to $25.6 million in 2022, then crashed by 86.56% to $3.4 million in 2023, then spiked by 297.85% to $13.7 million in 2024, then tumbled by 99.86% to $38,000 in 2025.
  • Its Capital Expenditures stands at $38,000 for Q2 2025, versus $7.6 million for Q1 2025 and $13.7 million for Q4 2024.